Nifty

:

22819.60

Sensex

:

73583.22

-486.85 (-2.09%)
-1690.23 (-2.25%)

Login

Nifty
Sensex

:
:

22819.60
73583.22

-486.85 (-2.09%)
-1690.23 (-2.25%)

Valiant Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

45/99

BSE: 543998 | NSE: VALIANTLAB

Watchlist

NSE BSE

53.57

27-Mar-2026

Open
High
Low
Previous Close

57.9
57.9
53
56.83

Volume
Traded Value (lacs)
52 Week High
52 Week Low

105694
5825670.17
115.54
49.51

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

289.70
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

323.72
N/A
0.93

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-26.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
2.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
110.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 54.74 35.23 55.38% 45.99 21.48 114.11% 51.01 18.88 170.18% 57.77 30.58 88.91%
Expenses 54.49 34.61 57.44% 45.93 28.22 62.76% 48.64 21.27 128.68% 53.94 35.11 53.63%
EBITDA 0.25 0.62 -59.68% 0.06 -6.74 - 2.36 -2.39 - 3.83 -4.53 -
EBIDTM 0.46% 1.77% 0.13% -31.38% 4.63% -12.65% 6.63% -14.81%
Other Income 0.61 0.67 -8.96% 0.85 1.93 -55.96% 0.67 2.17 -69.12% 0.65 2.50 -74.00%
Interest 0.03 0.06 -50.00% 0.14 0.01 1,300.00% 0.07 0.05 40.00% 0.06 0.02 200.00%
Depreciation 0.72 0.51 41.18% 0.51 0.51 0.00% 0.51 0.50 2.00% 0.51 0.50 2.00%
PBT 0.11 0.72 -84.72% 0.26 -5.32 - 2.45 -0.77 - 3.92 -2.55 -
Tax 0.08 -0.88 - 0.09 0.66 -86.36% 0.63 0.23 173.91% 0.69 -1.33 -
PAT 0.03 1.60 -98.12% 0.17 -5.98 - 1.82 -1.01 - 3.24 -1.22 -
PATM 0.06% 4.54% 0.37% -27.86% 3.56% -5.32% 5.61% -3.98%
EPS 0.01 0.29 -96.55% 0.03 -1.10 - 0.33 -0.19 - 0.60 -0.22 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 52.46 35.23 48.91% 46.20 21.48 115.08% 46.82 18.88 147.99% 57.79 30.59 88.92%
Expenses 53.35 34.61 54.15% 46.12 28.22 63.43% 44.42 21.27 108.84% 53.96 35.12 53.64%
EBITDA -0.89 0.62 - 0.08 -6.74 - 2.40 -2.39 - 3.83 -4.53 -
EBIDTM -1.69% 1.77% 0.17% -31.38% 5.13% -12.65% 6.62% -14.81%
Other Income 0.63 1.58 -60.13% 0.87 3.36 -74.11% 0.66 2.81 -76.51% -2.31 2.50 -
Interest 0.68 0.06 1,033.33% 0.14 0.01 1,300.00% 0.07 0.05 40.00% 0.06 0.02 200.00%
Depreciation 2.05 0.52 294.23% 0.53 0.52 1.92% 0.53 0.53 0.00% 0.52 0.52 0.00%
PBT -2.99 1.62 - 0.28 -3.91 - 2.45 -0.16 - 0.94 -2.57 -
Tax 4.07 -0.73 - 0.08 0.83 -90.36% 0.63 0.35 80.00% 0.24 -1.33 -
PAT -7.06 2.34 - 0.20 -4.74 - 1.82 -0.51 - 0.70 -1.24 -
PATM -13.45% 6.65% 0.44% -22.08% 3.89% -2.70% 1.22% -4.05%
EPS -1.30 0.50 - 0.04 -1.01 - 0.39 -0.11 - 0.15 -0.26 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 209.51 133.36 182.05 333.91 291.52 Net Sales Growth 97.33% -26.75% -45.48% 14.54% Cost Of Goods Sold 181.35 116.05 167.52 276.52 234.22 Gross Profit 28.16 17.32 14.52 57.39 57.30 GP Margin 13.44% 12.99% 7.98% 17.19% 19.66% Total Expenditure 203.00 138.05 190.46 298.84 249.21 Power & Fuel Cost - 5.94 8.33 7.37 4.38 % Of Sales - 4.45% 4.58% 2.21% 1.50% Employee Cost - 4.39 4.31 4.61 3.06 % Of Sales - 3.29% 2.37% 1.38% 1.05% Manufacturing Exp. - 3.78 6.15 5.13 3.93 % Of Sales - 2.83% 3.38% 1.54% 1.35% General & Admin Exp. - 0.84 0.78 0.90 0.53 % Of Sales - 0.63% 0.43% 0.27% 0.18% Selling & Distn. Exp. - 1.82 2.00 2.97 2.03 % Of Sales - 1.36% 1.10% 0.89% 0.70% Miscellaneous Exp. - 5.24 1.37 1.34 1.06 % Of Sales - 3.93% 0.75% 0.40% 0.36% EBITDA 6.50 -4.69 -8.41 35.07 42.31 EBITDA Margin 3.10% -3.52% -4.62% 10.50% 14.51% Other Income 2.78 5.44 9.68 4.89 1.95 Interest 0.30 0.18 0.08 0.25 0.07 Depreciation 2.25 2.02 1.95 1.56 2.49 PBT 6.74 -1.45 -0.75 38.14 41.70 Tax 1.49 0.70 -1.09 9.14 14.21 Tax Rate 22.11% -48.28% 145.33% 23.96% 34.08% PAT 5.26 -2.15 0.34 29.00 27.50 PAT before Minority Interest 5.26 -2.15 0.34 29.00 27.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.51% -1.61% 0.19% 8.68% 9.43% PAT Growth 179.58% - -98.83% 5.45% EPS 0.97 -0.40 0.06 5.34 5.06

Description TTM Mar 25 Mar 24 Mar 23
Net Sales 203.27 133.38 182.06 333.91 Net Sales Growth 91.44% -26.74% -45.48% Cost Of Goods Sold 173.24 116.06 167.53 276.52 Gross Profit 30.03 17.32 14.53 57.39 GP Margin 14.77% 12.99% 7.98% 17.19% Total Expenditure 197.85 138.08 190.47 298.84 Power & Fuel Cost - 5.94 8.33 7.37 % Of Sales - 4.45% 4.58% 2.21% Employee Cost - 4.39 4.31 4.61 % Of Sales - 3.29% 2.37% 1.38% Manufacturing Exp. - 3.78 6.15 5.13 % Of Sales - 2.83% 3.38% 1.54% General & Admin Exp. - 0.84 0.78 0.90 % Of Sales - 0.63% 0.43% 0.27% Selling & Distn. Exp. - 1.82 2.00 2.97 % Of Sales - 1.36% 1.10% 0.89% Miscellaneous Exp. - 5.24 1.37 1.34 % Of Sales - 3.93% 0.75% 0.40% EBITDA 5.42 -4.70 -8.41 35.07 EBITDA Margin 2.67% -3.52% -4.62% 10.50% Other Income -0.15 5.45 9.68 4.89 Interest 0.95 0.18 0.08 0.25 Depreciation 3.63 2.09 1.97 1.56 PBT 0.68 -1.51 -0.77 38.14 Tax 5.02 0.69 -1.09 9.14 Tax Rate 738.24% -45.70% 141.56% 23.96% PAT -4.34 -2.20 0.32 29.00 PAT before Minority Interest -4.34 -2.20 0.32 29.00 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin -2.14% -1.65% 0.18% 8.68% PAT Growth 0.00% - -98.90% EPS -0.80 -0.41 0.06 5.34

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 234.38 236.88 100.49 71.46 Share Capital 43.45 43.45 32.56 16.28 Total Reserves 190.93 193.43 67.93 55.18 Non-Current Liabilities 61.95 61.48 61.75 60.92 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 59.40 59.40 59.40 59.40 Long Term Provisions 0.09 0.08 0.08 0.00 Current Liabilities 20.95 26.36 50.52 49.43 Trade Payables 19.40 24.76 47.30 46.44 Other Current Liabilities 1.41 1.48 3.10 1.55 Short Term Borrowings 0.00 0.00 0.00 1.28 Short Term Provisions 0.14 0.12 0.12 0.16 Total Liabilities 317.28 324.72 212.76 181.81 Net Block 30.02 31.61 29.97 22.23 Gross Block 42.77 42.35 38.76 29.75 Accumulated Depreciation 12.75 10.74 8.79 7.53 Non Current Assets 198.06 115.46 30.80 25.01 Capital Work in Progress 0.17 0.22 0.05 1.45 Non Current Investment 165.06 80.97 0.01 0.00 Long Term Loans & Adv. 2.82 2.66 0.77 1.34 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 119.22 209.27 181.96 156.80 Current Investments 0.00 37.61 34.02 0.40 Inventories 3.96 10.02 13.04 15.80 Sundry Debtors 72.10 45.72 88.57 110.77 Cash & Bank 27.34 96.72 0.46 20.13 Other Current Assets 15.82 2.01 1.24 0.88 Short Term Loans & Adv. 15.42 17.19 44.64 8.81 Net Current Assets 98.27 182.90 131.44 107.37 Total Assets 317.28 324.73 212.76 181.81

Description Mar 25 Mar 24 Mar 23
Shareholder's Funds 234.31 236.86 100.49 Share Capital 43.45 43.45 32.56 Total Reserves 190.86 193.41 67.93 Non-Current Liabilities 106.93 76.75 61.75 Secured Loans 44.95 15.26 0.00 Unsecured Loans 59.40 59.40 59.40 Long Term Provisions 0.13 0.08 0.08 Current Liabilities 59.62 29.08 50.73 Trade Payables 40.72 25.93 47.30 Other Current Liabilities 1.84 1.65 3.31 Short Term Borrowings 16.86 1.39 0.00 Short Term Provisions 0.20 0.12 0.12 Total Liabilities 400.86 342.69 212.97 Net Block 48.44 50.05 48.12 Gross Block 70.67 70.21 66.31 Accumulated Depreciation 22.23 20.16 18.19 Non Current Assets 208.24 117.14 62.39 Capital Work in Progress 155.78 42.65 0.68 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 4.02 24.44 13.59 Other Non Current Assets 0.00 0.00 0.00 Current Assets 192.62 225.54 150.58 Current Investments 0.00 37.61 34.02 Inventories 3.99 10.02 13.04 Sundry Debtors 72.12 45.73 88.57 Cash & Bank 75.99 106.21 1.34 Other Current Assets 40.52 2.02 1.24 Short Term Loans & Adv. 39.71 23.96 12.37 Net Current Assets 133.00 196.47 99.85 Total Assets 400.86 342.68 212.97

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -21.90 48.78 22.96 2.25 PBT -1.45 -0.75 38.14 41.70 Adjustment 4.22 2.03 1.82 3.06 Changes in Working Capital -27.86 46.53 -8.20 -28.05 Cash after chg. in Working capital -25.09 47.80 31.76 16.72 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid 3.19 0.98 -8.80 -14.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.97 -182.73 -21.18 -12.24 Net Fixed Assets -0.37 -3.76 -7.61 Net Investments -46.48 -84.55 -33.63 Others 71.82 -94.42 20.06 Cash from Financing Activity -0.50 135.80 -1.53 6.18 Net Cash Inflow / Outflow 2.57 1.85 0.24 -3.81 Opening Cash & Equivalents 2.23 0.38 0.13 3.94 Closing Cash & Equivalent 4.80 2.23 0.38 0.13

Description Mar 25 Mar 24 Mar 23
Cash From Operating Activity 1.31 1.89 56.05 PBT -1.51 -0.77 38.14 Adjustment 4.29 2.04 1.56 Changes in Working Capital -3.93 -0.37 25.16 Cash after chg. in Working capital -1.15 0.90 64.85 Interest Paid 0.00 0.00 0.00 Tax Paid 2.47 0.98 -8.80 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -52.77 -143.88 -55.17 Net Fixed Assets -0.37 -3.76 Net Investments -46.48 -84.55 Others -5.92 -55.57 Cash from Financing Activity 44.65 152.45 -0.93 Net Cash Inflow / Outflow -6.80 10.46 -0.05 Opening Cash & Equivalents 11.72 1.26 1.31 Closing Cash & Equivalent 4.92 11.72 1.26

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 50.07 50.60 30.86 21.95 ROA -0.67% 0.13% 14.70% 15.12% ROE -0.91% 0.20% 33.73% 38.48% ROCE -0.43% -0.30% 26.29% 31.62% Fixed Asset Turnover 3.13 4.49 9.75 9.80 Receivable days 161.23 134.62 108.95 138.69 Inventory Days 19.12 23.11 15.77 19.79 Payable days 69.46 78.50 61.86 72.37 Cash Conversion Cycle 110.90 79.23 62.85 86.11 Total Debt/Equity 0.25 0.25 0.59 0.85 Interest Cover -7.26 -8.67 151.32 572.29

Description Mar 25 Mar 24 Mar 23
Book Value (Rs.) 50.05 50.60 30.86 ROA -0.59% 0.12% 13.62% ROE -0.93% 0.19% 28.86% ROCE -0.40% -0.29% 24.01% Fixed Asset Turnover 1.89 2.67 5.04 Receivable days 161.25 134.62 96.82 Inventory Days 19.16 23.11 14.26 Payable days 104.79 79.77 62.43 Cash Conversion Cycle 75.62 77.97 48.64 Total Debt/Equity 0.52 0.32 0.59 Interest Cover -7.63 -8.89 151.32

Top Investors:

Annual Reports:

News Update:

Valiant Laboratories - Quarterly Results
12th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback